Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Stroke

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 126 articles: HTML format

Single Articles

November 2022
1. ZUERCHER MD, Harvey DJ, Au LE, Shadyab AH, et al
   Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women.
   Int J Cardiol. 2022;367:99-104.
   PubMed     Abstract available
   
   
   
2. HAMATANI Y, Kato T, Morimoto T, Iguchi M, et al
   Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure.
   Int J Cardiol. 2022 Nov 11. pii: S0167-5273(22)01705.
   PubMed     Abstract available
   
   
   
3. KRITTANAWONG C, Yue B, Khawaja M, Kumar A, et al
   Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States.
   Int J Cardiol. 2022 Nov 7. pii: S0167-5273(22)01646.
   PubMed     Abstract available
   
   
   
4. CAI J, Zhang L, Chen C, Ge J, et al
   Association between serum klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007-2016.
   Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01697.
   PubMed     Abstract available
   
   
   
5. DU L, Zhang Y, Wang P, Li Z, et al
   GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?
   Int J Cardiol. 2022;366:31.
   PubMed    
   
   
   October 2022
6. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
   Screening for atrial fibrillation to prevent stroke in elderly individuals with or without preexisting cardiovascular disease: A post hoc analysis of the randomized LOOP study.
   Int J Cardiol. 2022 Oct 31. pii: S0167-5273(22)01678.
   PubMed     Abstract available
   
   
   
7. VANDENBRIELE C, Van Edom C, Tavazzi G
   Anticoagulant management for transition from failed thrombolysis to extra-corporeal membrane oxygenation in patients with high-risk pulmonary embolism: A thoughtful approach.
   Int J Cardiol. 2022 Oct 22. pii: S0167-5273(22)01649.
   PubMed     Abstract available
   
   
   
8. OLIVERI F, Montalto C, Tua L, Lanzillo G, et al
   Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysis.
   Int J Cardiol. 2022;365:123-130.
   PubMed     Abstract available
   
   
   
9. JIANG N, Wang Z, Deng Q, Zhou Y, et al
   Low-intensity focused ultrasound guided dodecafluoropentane-loaded acoustic phase-change nanoparticles for treatment of porcine coronary microthromboembolism.
   Int J Cardiol. 2022 Oct 5. pii: S0167-5273(22)01465.
   PubMed     Abstract available
   
   
   September 2022
10. MAI AS, Matetic A, Elgendy IY, Mattei JL, et al
    The Association Between Cancer Diagnosis, Care, and Outcomes in 1 Million Patients Hospitalized for Acute Pulmonary Embolism.
    Int J Cardiol. 2022 Sep 24. pii: S0167-5273(22)01399.
    PubMed     Abstract available
    
    
    
11. SOKHAL BS, Matetic A, Paul TK, Velagapudi P, et al
    Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01387.
    PubMed     Abstract available
    
    
    
12. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    PubMed     Abstract available
    
    
    
13. VERGARO G, Aimo A, Castiglione V, Emdin M, et al
    Stroke in ATTR cardiac amyloidosis: Does only rhythm matter?
    Int J Cardiol. 2022;363:127-128.
    PubMed    
    
    
    
14. PEREIRA MQ, David C, Almeida AG, Brito D, et al
    Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis.
    Int J Cardiol. 2022;362:76-82.
    PubMed     Abstract available
    
    
    August 2022
15. HWANG IC, Kim CH
    Reply to "GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?"
    Int J Cardiol. 2022 Aug 23. pii: S0167-5273(22)01257.
    PubMed    
    
    
    
16. IWAKAWA H, Terata K, Kato R, Kaimori R, et al
    Utility of P-wave abnormalities for distinguishing embolic stroke from non-embolic stroke.
    Int J Cardiol. 2022 Aug 23. pii: S0167-5273(22)01247.
    PubMed     Abstract available
    
    
    
17. CHEN M, Sun J, Wang QS, Zhang PP, et al
    Long-term outcome of combined catheter ablation and left atrial appendage closure in atrial fibrillation patients.
    Int J Cardiol. 2022 Aug 8. pii: S0167-5273(22)01174.
    PubMed     Abstract available
    
    
    
18. BRUNS F, Dobrev D, Fender AC
    Persisting stroke risk in patients with atrial fibrillation despite proper anticoagulation - Unmet clinical needs.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01186.
    PubMed    
    
    
    
19. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01120.
    PubMed     Abstract available
    
    
    July 2022
20. DE LUCA G, Verdoia M, Morici N, Ferri LA, et al
    Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial.
    Int J Cardiol. 2022 Jul 27. pii: S0167-5273(22)01104.
    PubMed     Abstract available
    
    
    
21. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    PubMed     Abstract available
    
    
    
22. MOLEK P, Chmiel J, Zabczyk M, Malinowski KP, et al
    Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01103.
    PubMed     Abstract available
    
    
    
23. DIXON LK, Akberali U, Di Tommaso E, George SJ, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022;359:20-27.
    PubMed     Abstract available
    
    
    
24. GOEL A, Singhal M, Malik AH, Gupta R, et al
    Patent foramen ovale closure for recurrent stroke prevention: Recent evidence towards individualized decision-making.
    Int J Cardiol. 2022;358:25.
    PubMed    
    
    
    June 2022
25. KORSHOLM K, Valentin JB, Damgaard D, Diener HC, et al
    Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Int J Cardiol. 2022 Jun 30. pii: S0167-5273(22)01019.
    PubMed     Abstract available
    
    
    
26. BAKER HE, Tune JD, Mather KJ, Blaettner BS, et al
    Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na+/H+ exchanger-1.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01006.
    PubMed     Abstract available
    
    
    
27. KIM CH, Hwang IC, Choi HM, Ahn CH, et al
    Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00927.
    PubMed     Abstract available
    
    
    
28. KANY S, Kuck KH, Brachmann J, Andresen D, et al
    Outcomes in patients experiencing complications associated with atrial fibrillation ablation: Data from the German ablation registry.
    Int J Cardiol. 2022 Jun 12. pii: S0167-5273(22)00918.
    PubMed     Abstract available
    
    
    May 2022
29. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    PubMed     Abstract available
    
    
    
30. PRACON R, Zielinski K, Bangalore S, Konka M, et al
    Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Int J Cardiol. 2022;354:17-21.
    PubMed     Abstract available
    
    
    April 2022
31. DALE Z, Chandrashekar P, Al-Rashdan L, Gill S, et al
    Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosis.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00559.
    PubMed     Abstract available
    
    
    
32. XUE W, Tian Y, Jing L, Li R, et al
    Sex difference in the correlation between carotid artery diameter and prevalence of stroke: Insights from a Chinese population.
    Int J Cardiol. 2022;353:103-108.
    PubMed     Abstract available
    
    
    
33. JOLOBE OMP
    Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00509.
    PubMed    
    
    
    
34. LI L, Dai M, Fu Y
    Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00508.
    PubMed    
    
    
    
35. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    PubMed     Abstract available
    
    
    March 2022
36. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    PubMed     Abstract available
    
    
    
37. SADEGHIPOUR P, Pouraliakbar H, Parsaee M, Shojaeifard M, et al
    RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00396.
    PubMed     Abstract available
    
    
    February 2022
38. MAGNANI G, Bricoli S, Ardissino M, Maglietta G, et al
    Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00249.
    PubMed     Abstract available
    
    
    
39. GONZALEZ PEREZ A, Balabanova Y, Saez ME, Brobert G, et al
    Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom.
    Int J Cardiol. 2022 Feb 2. pii: S0167-5273(22)00190.
    PubMed     Abstract available
    
    
    
40. ORSINI E, Marzilli M, Zito GB, Carbone V, et al
    Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study.
    Int J Cardiol. 2022 Feb 1. pii: S0167-5273(22)00182.
    PubMed     Abstract available
    
    
    January 2022
41. LI X, Jia Z, Yan Y
    Ticagrelor for prevention of stroke and cognitive impairment in patients with vascular high-risk factors: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 Jan 31. pii: S0167-5273(22)00186.
    PubMed     Abstract available
    
    
    
42. FU EL, Clase CM, Janse RJ, Lindholm B, et al
    Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00131.
    PubMed     Abstract available
    
    
    December 2021
43. HUANG CK, Wang JC, Chung CH, Chen SJ, et al
    The risk and timing of acute ischemic stroke after electrical cardioversion for atrial fibrillation in Taiwan: A nationwide population-based cohort study.
    Int J Cardiol. 2021 Dec 23. pii: S0167-5273(21)02038.
    PubMed     Abstract available
    
    
    
44. D'ANCONA G, Arslan F, Safak E, Weber D, et al
    Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation.
    Int J Cardiol. 2021 Dec 17. pii: S0167-5273(21)02019.
    PubMed     Abstract available
    
    
    
45. DI LULLO L, Lavalle C, Magnocavallo M, Mariani MV, et al
    New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation.
    Int J Cardiol. 2021;345:90-97.
    PubMed     Abstract available
    
    
    
46. BONAVENTURA A
    Assisted reproductive technologies and stroke: Risk factor, predictor of poor outcome, or both?
    Int J Cardiol. 2021;344:220-221.
    PubMed    
    
    
    November 2021
47. TANG Y, Liu S, Shi Y, He T, et al
    Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction.
    Int J Cardiol. 2021 Nov 24. pii: S0167-5273(21)01861.
    PubMed     Abstract available
    
    
    
48. RAHMAN MU, Amritphale A, Kumar S, Trice C, et al
    Assessment of independent clinical predictors of early readmission after percutaneous endoluminal left atrial appendage closure with the Watchman device using National Readmission Database.
    Int J Cardiol. 2021;343:21-26.
    PubMed     Abstract available
    
    
    
49. BONETTI NR, Meister TA, Soria R, Akhmedov A, et al
    In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.
    Int J Cardiol. 2021;343:92-101.
    PubMed     Abstract available
    
    
    
50. MARSTON XL, Wang R, Yeh YC, Zimmermann L, et al
    Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study.
    Int J Cardiol. 2021 Nov 12. pii: S0167-5273(21)01776.
    PubMed     Abstract available
    
    
    
51. ZHENG X, Wang F, Zhang J, Cui X, et al
    Using machine learning to predict atrial fibrillation diagnosed after ischemic stroke.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01773.
    PubMed     Abstract available
    
    
    
52. SILVERIO A, Di Maio M, Buccheri S, De Luca G, et al
    Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01784.
    PubMed     Abstract available
    
    
    September 2021
53. RADINOVIC A, Falasconi G, Marzi A, D'Angelo G, et al
    Long-term outcome of left atrial appendage occlusion with multiple devices.
    Int J Cardiol. 2021 Sep 29. pii: S0167-5273(21)01492.
    PubMed     Abstract available
    
    
    
54. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    PubMed    
    
    
    
55. SHANG L, Sun H, Tang B
    Screening for atrial fibrillation in older populations: Outcome is more important than detection.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01486.
    PubMed    
    
    
    
56. SPARROW RT, Sanjoy SS, Lindman BR, Tang GHL, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing transcatheter mitral edge-to-edge repair.
    Int J Cardiol. 2021 Sep 20. pii: S0167-5273(21)01478.
    PubMed     Abstract available
    
    
    
57. AIT-OUFELLA H, Yu M, Kotti S, Georges A, et al
    Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 study.
    Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01379.
    PubMed     Abstract available
    
    
    
58. AL-RUBAISH AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, et al
    Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01319.
    PubMed     Abstract available
    
    
    
59. ANDERSEN P, Kragholm K, Torp-Pedersen C, Jensen SE, et al
    The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.
    Int J Cardiol. 2021 Sep 6. pii: S0167-5273(21)01321.
    PubMed     Abstract available
    
    
    August 2021
60. WANG W, Liu Y, Liu J, Yin P, et al
    Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: Empirical evidence from national mortality surveillance system.
    Int J Cardiol. 2021 Aug 25. pii: S0167-5273(21)01300.
    PubMed     Abstract available
    
    
    
61. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    PubMed     Abstract available
    
    
    
62. SEN J, Tonkin A, Varigos J, Fonguh S, et al
    Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.
    Int J Cardiol. 2021;337:9-15.
    PubMed     Abstract available
    
    
    
63. ZUIN M, Rigatelli G
    Thrombus straddling a patent foramen ovale: Also a myocardial infarction matter?
    Int J Cardiol. 2021 Aug 7. pii: S0167-5273(21)01206.
    PubMed    
    
    
    July 2021
64. JAMAL J, O'Loughlin A, French JK
    A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Jul 31. pii: S0167-5273(21)01210.
    PubMed    
    
    
    
65. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    PubMed     Abstract available
    
    
    
66. JACOBSEN MR, Engstrom T, Torp-Pedersen C, Gislason G, et al
    Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01192.
    PubMed     Abstract available
    
    
    
67. NEDIOS S
    Screening for atrial fibrillation: Does cardiovascular disease reduce the probability of detection?
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01097.
    PubMed    
    
    
    
68. VEDOVATI MC, Tratar G, Mavri A, Mazzetti M, et al
    Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01099.
    PubMed     Abstract available
    
    
    
69. SHAH P, Jimenez-Ruiz A, Gibson A, Vargas-Gonzalez JC, et al
    Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01101.
    PubMed     Abstract available
    
    
    June 2021
70. VAN DER MATEN G, Dijkstra S, Meijs MFL, von Birgelen C, et al
    Cardiac imaging in ischemic stroke or transient ischemic attack of undetermined cause: Systematic review & meta-analysis.
    Int J Cardiol. 2021 Jun 28. pii: S0167-5273(21)01083.
    PubMed     Abstract available
    
    
    
71. FAROUX L, Cruz-Gonzalez I, Arzamendi D, Freixa X, et al
    Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Int J Cardiol. 2021;333:77-82.
    PubMed     Abstract available
    
    
    May 2021
72. JANSSENS GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, et al
    Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome.
    Int J Cardiol. 2021 May 15. pii: S0167-5273(21)00830.
    PubMed     Abstract available
    
    
    
73. MINHAS A, Shade JK, Cho SM, Michos ED, et al
    The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19.
    Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00823.
    PubMed     Abstract available
    
    
    
74. MANNINA C, Jin Z, Matsumoto K, Ito K, et al
    Frequency of cardiac arrhythmias in older adults: Findings from the Subclinical Atrial Fibrillation and Risk of Ischemic Stroke (SAFARIS) study.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00818.
    PubMed     Abstract available
    
    
    
75. MIRO O, Llorens P, Jimenez S, Pinera P, et al
    Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.
    Int J Cardiol. 2021;330:268-272.
    PubMed    
    
    
    
76. SHIN SY, Park JW
    Is the Left Atrial Appendage (LAA) anatomical shape really meaningless measure for stroke risk assessment?
    Int J Cardiol. 2021;330:80-81.
    PubMed    
    
    
    April 2021
77. LANGER A, Healey JS, Quinn FR, Honos G, et al
    Detection of atrial fibrillation in asymptomatic at-risk individuals.
    Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00737.
    PubMed     Abstract available
    
    
    
78. ELGENDY IY, Mansoor H, Pepine CJ
    Reproductive lifespan and incident stroke risk among post-menopausal women: Is it time for sex-specific risk prediction tools?
    Int J Cardiol. 2021;328:218-219.
    PubMed    
    
    
    
79. MISHRA SR, Waller M, Chung HF, Mishra GD, et al
    Association of the length of oestrogen exposure with risk of incident stroke in postmenopausal women: Insights from a 20-year prospective study.
    Int J Cardiol. 2021;328:206-214.
    PubMed     Abstract available
    
    
    March 2021
80. GAWALKO M, Dobrev D
    Oral anticoagulation and therapy of atrial flutter: discontinuation of anticoagulation revisited.
    Int J Cardiol. 2021 Mar 17. pii: S0167-5273(21)00479.
    PubMed    
    
    
    
81. STRAW S, Witte KK
    Closing the loop: Delivering personalised care for patients with cryptogenic stroke.
    Int J Cardiol. 2021;327:100-101.
    PubMed    
    
    
    
82. KRISHNAPPA D, Wang W, Rooney MR, Norby FL, et al
    Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00394.
    PubMed     Abstract available
    
    
    
83. DE HEIDE J, de Wit A, Bhagwandien RE, Assaf A, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population.
    Int J Cardiol. 2021;326:98-102.
    PubMed     Abstract available
    
    
    February 2021
84. GIEHM-REESE M, Johansen MN, Kronborg MB, Jensen HK, et al
    Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study.
    Int J Cardiol. 2021 Feb 27. pii: S0167-5273(21)00366.
    PubMed     Abstract available
    
    
    
85. KOZIEL M, Mihajlovic M, Nedeljkovic M, Pavlovic N, et al
    Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00294.
    PubMed     Abstract available
    
    
    
86. COWAN LT, Buck B, Schwind JS, Lutsey PL, et al
    Triggering of cardiovascular disease by infection type: The Atherosclerosis Risk in Communities study (ARIC).
    Int J Cardiol. 2021;325:155-160.
    PubMed     Abstract available
    
    
    
87. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    PubMed     Abstract available
    
    
    January 2021
88. HARIHARAN P, Giordano N, Muzikansky A, Kabrhel C, et al
    Clinical factors associated with massive pulmonary embolism and PE-related adverse clinical events.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00139.
    PubMed     Abstract available
    
    
    
89. KALARIA SN, Zhu H, Liu Q, Florian J, et al
    Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00106.
    PubMed     Abstract available
    
    
    
90. DUDZINSKA-SZCZERBA K, Michalowska I, Piotrowski R, Sikorska A, et al
    Assessment of the left atrial appendage morphology in patients after ischemic stroke - The ASSAM study.
    Int J Cardiol. 2021 Jan 29. pii: S0167-5273(21)00080.
    PubMed     Abstract available
    
    
    
91. ZWEIKER D, Manninger M, Sieghartsleitner R, Ebner J, et al
    No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
    Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00082.
    PubMed     Abstract available
    
    
    
92. DE ROQUETAILLADE C, Chousterman BG, Tomasoni D, Zeitouni M, et al
    Unusual arterial thrombotic events in Covid-19 patients.
    Int J Cardiol. 2021;323:281-284.
    PubMed     Abstract available
    
    
    
93. HWANG J, Lee SR, Park HS, Lee YS, et al
    Adherence to dabigatran and the influence of dabigatran-induced gastrointestinal discomfort in the real-world practice.
    Int J Cardiol. 2021;323:77-82.
    PubMed     Abstract available
    
    
    
94. GU K, Mahtta D, Kaneria A, Sharedalal P, et al
    Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR(R) PINNACLE Registry.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34312.
    PubMed     Abstract available
    
    
    
95. SCOGNAMIGLIO G, Fusco F, Hankel TC, Bouma BJ, et al
    Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.
    Int J Cardiol. 2021;322:129-134.
    PubMed     Abstract available
    
    
    December 2020
96. FEMIA G, Zhu D, Choudhary P, Ross SB, et al
    Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults.
    Int J Cardiol. 2020 Dec 10. pii: S0167-5273(20)34265.
    PubMed     Abstract available
    
    
    
97. LENG WX, Yang JG, Li XD, Jiang WY, et al
    Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
    Int J Cardiol. 2020 Dec 8. pii: S0167-5273(20)34245.
    PubMed     Abstract available
    
    
    
98. CAPIAU A, De Backer T, Grymonprez M, Lahousse L, et al
    Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and EHRA Practical Guide.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34231.
    PubMed     Abstract available
    
    
    November 2020
99. KOBO O, Contractor T, Mohamed MO, Parwani P, et al
    Impact of pre-existent vascular and poly-vascular disease on acute myocardial infarction management and outcomes: An analysis of 2 million patients from the National Inpatient Sample.
    Int J Cardiol. 2020 Nov 30. pii: S0167-5273(20)34220.
    PubMed     Abstract available
    
    
    
100. CASU G, D'Angelo G, Ugo F, Ronco F, et al
     Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study.
     Int J Cardiol. 2020 Nov 24. pii: S0167-5273(20)34168.
     PubMed     Abstract available
     
     
     
101. DOMINGUEZ-ERQUICIA P, Raposeiras-Roubin S, Abbu-Assi E, Cespon-Fernandez M, et al
     Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation.
     Int J Cardiol. 2020 Nov 18. pii: S0167-5273(20)34146.
     PubMed     Abstract available
     
     
     
102. MARKS D, Ho R, Then R, Weinstock JL, et al
     Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence.
     Int J Cardiol. 2020 Nov 10. pii: S0167-5273(20)34140.
     PubMed     Abstract available
     
     
     
103. ANDERSSON T, Aspberg S
     Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study.
     Int J Cardiol. 2020 Nov 2. pii: S0167-5273(20)34068.
     PubMed     Abstract available
     
     
     October 2020
104. VALLABHAJOSYULA S
     Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
     Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.
     PubMed    
     
     
     
105. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
     Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
     Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
     PubMed     Abstract available
     
     
     
106. FENDER AC, Dobrev D
     The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation.
     Int J Cardiol. 2020 Oct 1. pii: S0167-5273(20)33897.
     PubMed    
     
     
     September 2020
107. PACHOLCZAK-MADEJ R, Bazan-Socha S, Zareba L, Undas A, et al
     Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study.
     Int J Cardiol. 2020 Sep 12. pii: S0167-5273(20)33818.
     PubMed     Abstract available
     
     
     August 2020
108. CHANTRARAT T, Krittayaphong R
     Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population,Data from the COOL-AF Thailand registry.
     Int J Cardiol. 2020 Aug 20. pii: S0167-5273(20)33651.
     PubMed     Abstract available
     
     
     
109. LIU J, Wang Y, Guo W, Cheng Y, et al
     Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
     Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33573.
     PubMed     Abstract available
     
     
     
110. RUTLAND J, Ayoub K, Etaee F, Ogunbayo G, et al
     CHA2DS2-VASc and readmission with new-onset atrial fibrillation, atrial flutter, or acute cerebrovascular accident.
     Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33554.
     PubMed     Abstract available
     
     
     
111. MALAVASI VL, Zoccali C, Brandi MC, Micali G, et al
     Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study.
     Int J Cardiol. 2020 Aug 12. pii: S0167-5273(20)33555.
     PubMed     Abstract available
     
     
     
112. CARRERO JJ, Trevisan M, Evans M, Svennberg E, et al
     Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation.
     Int J Cardiol. 2020 Aug 5. pii: S0167-5273(20)33530.
     PubMed     Abstract available
     
     
     July 2020
113. LOPES RD, Berger SE, Di Fusco M, Kang A, et al
     A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation.
     Int J Cardiol. 2020 Jul 4. pii: S0167-5273(20)33439.
     PubMed     Abstract available
     
     
     June 2020
114. HUANG J, Wu N, Xiang Y, Wu L, et al
     Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation.
     Int J Cardiol. 2020 Jun 27. pii: S0167-5273(20)33408.
     PubMed     Abstract available
     
     
     
115. AKHTAR T, Fratti JDC, Mattumpuram J, Fugar S, et al
     Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience.
     Int J Cardiol. 2020 Jun 26. pii: S0167-5273(20)33410.
     PubMed     Abstract available
     
     
     
116. PATTI G, Pecen L, Manu MC, Huber K, et al
     Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies.
     Int J Cardiol. 2020 Jun 20. pii: S0167-5273(20)33388.
     PubMed     Abstract available
     
     
     May 2020
117. JAUME FP, Aleix OS, Nuria RG, Jordi PR, et al
     High incidence of subclinical atrial fibrillation in patients with syncope monitored with implantable cardiac monitor.
     Int J Cardiol. 2020 May 26. pii: S0167-5273(20)32451.
     PubMed     Abstract available
     
     
     April 2020
118. PUGLIESE NR, Masi S
     Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease.
     Int J Cardiol. 2020 Apr 21. pii: S0167-5273(20)31424.
     PubMed    
     
     
     
119. GEARY L, Hasselstrom J, Carlsson AC, Schenck-Gustafsson K, et al
     An audit & feedback intervention for improved anticoagulant use in patients with atrial fibrillation in primary care.
     Int J Cardiol. 2020 Apr 12. pii: S0167-5273(20)30628.
     PubMed    
     
     
     March 2020
120. YUAN S, Lin A, He QQ, Burgess S, et al
     Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
     Int J Cardiol. 2020 Mar 21. pii: S0167-5273(20)30701.
     PubMed     Abstract available
     
     
     
121. ZAKERI R, Morgan JM, Phillips P, Kitt S, et al
     Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.
     Int J Cardiol. 2020 Mar 3. pii: S0167-5273(19)34926.
     PubMed     Abstract available
     
     
     February 2020
122. NEDIOS S, Dobrev D
     Electrocardiographic sex-related differences in patients with atrial fibrillation: Do they allow a better risk stratification?
     Int J Cardiol. 2020 Feb 19. pii: S0167-5273(20)30218.
     PubMed    
     
     
     January 2020
123. BAE JH, Corban MT, Seo YH, Kim T, et al
     Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events.
     Int J Cardiol. 2020;299:26-30.
     PubMed     Abstract available
     
     
     
124. RODRIGUEZ-CASTRO E, Hervella P, Lopez-Dequidt I, Arias-Rivas S, et al
     NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack.
     Int J Cardiol. 2020;298:93-97.
     PubMed     Abstract available
     
     
     December 2019
125. BAHIT MC, Granger CB, Alexander JH, Mulder H, et al
     Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.
     Int J Cardiol. 2019 Dec 30. pii: S0167-5273(19)34634.
     PubMed     Abstract available
     
     
     October 2019
126. LUCIJANIC M, Jurin I, Jurin H, Lucijanic T, et al
     Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.
     Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)34260.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: